Smith & Nephew, GB0009223206

Smith & Nephew stock steadies as new USD 700 million bond reshapes its debt profile

Published on 09/10/2026 at 19:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Smith & Nephew stock trades just above its recent 12-month low as of September 10, 2026, while the company prices USD 700 million 5.750 percent notes due 2036 to refinance 2030 debt. The move extends its maturity profile and comes as London-listed shares are down about 27 percent over the past year.

Techniker prüfen Implantate im sterilen Reinraum eines Medizintechnik-Werks
Smith & Nephew plc (ISIN GB0009223206) fertigt orthopädische Implantate in sterilen Reinraum-Anlagen mit hoher Präzision, Illustration mit AI erstellt.

Smith & Nephew stock is trading close to its recent 12-month low, with the London-listed shares at around 1,031.00 pence on September 10, 2026, up about 0.5 percent intraday but still roughly 27 percent lower over the past year, according to Morningstar.

Bond issue reshapes Smith & Nephew's capital structure

According to Investegate on September 10, 2026, Smith & Nephew plc has completed the pricing of USD 700,000,000 5.750 percent notes due 2036, with the offering scheduled to close on September 11, 2026 subject to customary conditions.

As TipRanks reports, net proceeds of about USD 690.9 million from the 5.750 percent notes are earmarked primarily to finance a tender offer for Smith & Nephew's outstanding 2.032 percent senior notes due 2030, with remaining funds used for fees, expenses and general corporate purposes.

The refinancing effectively extends the company's debt maturity profile by replacing lower coupon 2030 notes with higher coupon 2036 notes, trading off a higher interest burden for a longer runway to service and repay its debt, as highlighted by Stock Titan.

Stock trades near 12-month low despite bond move

Smith & Nephew's US-traded shares on the New York Stock Exchange under the ticker SNN closed at USD 27.84 on September 9, 2026, down about 3.6 percent from the prior close of USD 28.87 and marking a fresh 12-month low of USD 27.56 during the session, as reported by Ad-hoc news.

Per MarketBeat, Smith & Nephew SNATS stock opened at USD 27.77 on September 10, 2026, with a twelve month low of USD 27.56 and a twelve month high of USD 38.59, underscoring how far the shares have fallen compared with their 12-month peak.

On the primary listing in London, Smith & Nephew shares traded at around 1,032.00 pence on September 10, 2026, up 0.63 percent intraday, while the five-day performance showed a decline of about 3.48 percent and the year-to-date performance indicated a drop of around 17.20 percent, according to price data cited by MarketScreener.

Analyst stance remains cautious with modest upside

Despite the bond issuance, the analyst consensus on Smith & Nephew stock remains relatively cautious. According to MarketBeat on September 10, 2026, one analyst rates the stock Buy, ten have Hold ratings and one has a Sell rating, resulting in a consensus Hold recommendation with an average price target of USD 30.93.

That consensus target of USD 30.93 stands about USD 3.37 above the recent closing price of USD 27.56 to USD 27.84 range, implying upside of roughly 12 percent from the latest US trading levels if the average target were reached, based on data from MarketBeat.

In the London market, MarketScreener notes that Smith & Nephew shares most recently closed at USD 13.89 equivalent, with an average analyst price objective of USD 17.02, representing about 22.56 percent potential upside, and an overall recommendation to hold the stock.

Debt refinancing risk and investor focus

For investors, the key question around the new USD 700 million notes is how the higher 5.750 percent coupon will affect Smith & Nephew's interest expense over time compared with the 2.032 percent senior notes due 2030 that are being refinanced, a spread of 3.718 percentage points that will directly increase annual financing costs as summarized by TipRanks.

According to Stock Titan, Smith & Nephew expects net proceeds of about USD 690.9 million after underwriting discounts from the 5.750 percent notes, which will be used mainly to repurchase the 2030 notes; the transaction extends the average maturity of its debt from 2030 to 2036 and is aimed at refining its capital structure.

A potential risk highlighted in the bond documentation is that the notes are not intended for retail investors in the United Kingdom or the European Economic Area, reflecting regulatory constraints and emphasizing that the issuance is targeted at institutional buyers, as stated by Investegate.

Smith & Nephew stock price and trading context

As of September 9, 2026, Smith & Nephew's primary reference price for investors is the London Stock Exchange quote under the ticker SN, where the shares closed near 1,025.50 pence, with a five-day variation of minus 3.48 percent and a year-to-date change of minus 17.20 percent, according to MarketScreener.

Smith & Nephew stock facts

  • Company: Smith & Nephew plc
  • ISIN: GB0009223206
  • Ticker: SN
  • Trading venue: London Stock Exchange
  • Price (as of September 9, 2026, 17:35): 1,025.50 GBX
  • Market capitalization: [value] [currency] (as of September 9, 2026)
  • Sector / Industry: Medical Devices
  • Index membership: FTSE 100

More news and analyses on Smith & Nephew stock

Disclaimer...

en | GB0009223206 | SMITH & NEPHEW | boerse | 70083217 | bgmi